Business
AstraZeneca sees no evidence of increased blood clot risk from vaccine – Sydney Morning Herald
The review comes after authorities in the Netherlands, Ireland, Denmark, Norway and Iceland suspended the use of the vaccine over concerns about side effects.
No cases of blood clotting disorders had been found yet in the Netherlands, the Dutch Health ministry said, adding there was no proof yet of a direct link between the vaccine and health effects reported in Denmark and Norway.
We cant allow any doubts about the vaccine, Dutch Health minister Hugo de Jonge said.
We have to make sure everything is right, so it is wise to pause for now.
AstraZeneca said additional testing has and is being conducted by the company and the European health authorities…
-
Business12 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business16 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business8 hours agoDicker Data rides the AI trend to double digit growth
-
Business11 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy